- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Protein Production
- Protein Analytics
- Bioinformatics
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Resources
Videos
A mother’s wish | The story of Angelman patient
A mother’s wish | The story of Angelman patient
“I wish that Max would speak and Mom would say to me at some point.”
The 5-year-old son of our colleague Jana van der Heide-Seidenspinner, HR Business Partner Wuppertal, suffers from Angelman syndrome – a rare genetic disease that manifests itself among other things by mental and physical limitations, developmental disorders and hyperactivity.
At WuXi Biologics, we work closely with our partners to develop breakthrough Therapeutika for rare disease patients. For example, we support Amicus Therapeutics in the development and manufacture of a drug to treat Pompe Disease.
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?